COVID-19 and Its Impact on the Biotech Ecosystem in Vancouver

Affordable Networking & Training
06/11/2020
Online

Join the Graduate Career Management Centre (CMC) and listen to panelists from local biotech companies talk about:

How the local biotech ecosystem has been impacted

  • How we have responded
  • What needs to be done
  • What the world looks like now for new graduates

PANEL

Malcom Kendall – Moderator – CEO and Cofounder, Microbiome Insights

Malcolm Kendall has over 28 years of operational management, entrepreneurial, venture capital investment and leadership experience, the majority of which has been focused on company creation and building value in technology and biotechnology companies.

David Main – Panelist – President & CEO at Abdera Pharmaceuticals Inc.

David Main has over 25 years of experience in the health sciences industry with a demonstrated ability to grow and finance pharmaceutical development companies.

Jennifer Hamilton, PhD – Panelist – Senior Director, New Ventures (Canada) and Advisor, Impact Investing, J&J Global Community Impact

Jennifer Hamilton has scouted, cross-sector, for new opportunities for Johnson & Johnson in Canada since 2010 – first with the Corporate Office of Science and Technology (COSAT) and now with J&J Innovation. As well, Jennifer serves as the industry representative on the Canadian Institutes of Health Research (CIHR, Canadian equivalent of NIH) Standing Committee on Ethics.

John Babcook – Panelist – SVP, Discovery Research, Zymeworks

John Babcook has served as Senior Vice President, Discovery Research since March 2016 and is responsible for target, antibody, and drug conjugate discovery and associated partnerships. For over 20 years, Mr. Babcook has made significant contributions to the international biopharmaceutical industry.

Any questions, please contact mbacareers@sfu.ca

Register

Comment